You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

64Cu-NOTA-PSMA-PEG-Cy5.5-C' dot tracer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in New York (drug, diagnostic test, other, procedure)

Recruiting
  • Prostate Cancer
  • (64Cu)-labeled PSMA-targeting particle tracer, or 64Cu-NOTA-PSMAi-PEG-Cy5.5-C' dots
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 7, 2022

Metastatic Prostate Cancer Trial in Perth (64Cu-DOTA-TLX592)

Recruiting
  • Metastatic Prostate Cancer
  • Perth, Western Australia, Australia
  • +1 more
Nov 25, 2022

Head and Neck Melanoma Trial in New York (fluorescent cRGDY-PEG-Cy5.5-C dots)

Recruiting
  • Head and Neck Melanoma
  • fluorescent cRGDY-PEG-Cy5.5-C dots
  • New York, New York
  • +1 more
Nov 23, 2022

Biochemical Recurrence of Malignant Tumor of Prostate Trial (64Cu-SAR-BBN)

Recruiting
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • Duarte, California
  • +7 more
Jan 15, 2023

Macrophage PET/CT Imaging Using 64Cu-DOTATATE for Diagnosis of

Recruiting
  • Cardiac Sarcoidosis
  • 64Cu-DOTATATE PET/CT scan
  • Copenhagen, Denmark
    Rigshospitalet
Nov 14, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jun 20, 2023

Brain Cancer, Pituitary Adenoma Trial in New York (89Zr-DFO-cRGDY-PEG-Cy5-C' dots PET Imaging, Blood and Urine samples)

Recruiting
  • Brain Cancer
  • Pituitary Adenoma
  • 89Zr-DFO-cRGDY-PEG-Cy5-C' dots PET Imaging
  • Blood and Urine samples
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 11, 2022

Solid Tumor, Positron-Emission Tomography(PET) Trial in Suzhou ([68Ga]Ga-NOTA-SNA002)

Not yet recruiting
  • Solid Tumor
  • Positron-Emission Tomography(PET)
  • [68Ga]Ga-NOTA-SNA002
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Aug 3, 2022

68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy

Enrolling by invitation
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Computed Tomography
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 16, 2023

Atrial Fibrillation, COVID-19, Cancer Trial in Boston (drug, device, procedure)

Recruiting
  • Atrial Fibrillation
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Dec 20, 2022

Bladder Cancer Trial in Shanghai ([68Ga]-NOTA-SGC8)

Recruiting
  • Bladder Cancer
  • [68Ga]-NOTA-SGC8
  • Shanghai, Shanghai, China
    Renji Hospital
Aug 14, 2023

Prostate Cancer, Renal Cancer, Urethral Cancer Trial in San Francisco (Copper-64 labeled Granzyme B (64Cu-GRIP B), Positron

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Copper-64 labeled Granzyme B (64Cu-GRIP B)
  • Positron Emission Tomography (PET)
  • San Francisco, California
    University of California, San Francisco
Jun 7, 2023

Prostate Cancer Trial (PSMA-radioguided surgery, ADT)

Not yet recruiting
  • Prostate Cancer
  • PSMA-radioguided surgery
  • ADT
  • (no location specified)
Sep 22, 2022

Biochemical Recurrence of Malignant Tumor of Prostate, Prostate Cancer, BCR Prostate Carcinoma Trial in China (68Ga-PSMA-11,

Not yet recruiting
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • +2 more
  • Changsha, China
  • +5 more
Apr 26, 2023

Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46,

Recruiting
  • Breast Carcinoma
  • +10 more
  • Computed Tomography
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Nov 29, 2022

CANF-Comb-II PET-MR in Atherosclerosis Multisite

Recruiting
  • Carotid Atherosclerosis
  • +2 more
  • Los Angeles, California
  • +1 more
Apr 27, 2023

Neuroendocrine Tumors Trial in Beijing (Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3)

Recruiting
  • Neuroendocrine Tumors
  • Al18F-NOTA-LM3
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Sep 20, 2023

Solid Tumors, Adult, Metastatic Cancer Trial in San Francisco (Gallium-68 labelled (68Ga-) FAP-2286, Positron Emission

Recruiting
  • Solid Tumors, Adult
  • Metastatic Cancer
  • Gallium-68 labelled (68Ga-) FAP-2286
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 1, 2022

Cancer Trial in Stockholm (68Ga-NOTA-PEG2-RM26)

Recruiting
  • Cancer
  • Stockholm, Sweden
    Karolinska University Hospital
Nov 23, 2023

Aldosterone-Producing Adenoma Trial in Chengdu ([18F]AlF-NOTA-pentixather PET/CT)

Recruiting
  • Aldosterone-Producing Adenoma
  • [18F]AlF-NOTA-pentixather PET/CT
  • Chengdu, Sichuan, China
    Sichuan Academy of Medical Sciences.Sichuan Provincial People's
Apr 3, 2023

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With

Recruiting
  • Pancreatic Cancer
  • +4 more
  • PET Scan
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 10, 2023

Extramedullary Myeloma Trial in Melbourne (Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent)

Not yet recruiting
  • Extramedullary Myeloma
  • Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Dec 18, 2022

Medullary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Carcinoma, Medullary Trial in Groningen (18F-PSMA-1007)

Not yet recruiting
  • Medullary Thyroid Cancer
  • +3 more
  • Groningen, Netherlands
    University Medical Centre Groningen
Sep 8, 2022

Prostate Cancer, Lymph Node Metastases Trial in Nijmegen (Radio guided surgery (RGS) using Indium-labelled PSMA)

Active, not recruiting
  • Prostate Cancer
  • Lymph Node Metastases
  • Radio guided surgery (RGS) using Indium-labelled PSMA
  • Nijmegen, Gelderland, Netherlands
  • +1 more
Apr 27, 2022

Prostatic Tumors, Castration-Resistant Trial in United States (64Cu-SAR-bisPSMA, 67Cu-SAR-bisPSMA)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Phoenix, Arizona
  • +6 more
May 23, 2022